General practice is good at finding medicines work. Searches identify patients overdue for monitoring. Letters arrive with dose changes. Requests come in for repeats and restarts. The harder part is making sure each item is finished — and knowing that it was.
What the evidence says
The PRACtICe study, commissioned by the General Medical Council, reviewed prescriptions in English general practices. It found prescribing or monitoring errors in 4.9% of prescription items. Monitoring errors were less common than prescribing errors, but the most common monitoring error was a simple one: the test was not requested.
At national level, research for the Department of Health and Social Care estimated that around 237 million medication errors occur each year in England. Most cause little or no harm, but of the errors judged potentially clinically significant, 71% were estimated to occur in primary care.
Monitoring of high-risk medicines is particularly sensitive to disruption. The OpenSAFELY analysis of medication safety indicators found that in early 2020, for example, on average across practices, 31% of patients on lithium had no level recorded in the previous three months, and 19% of patients on methotrexate had no recorded full blood count (practice-level means, not a count of patients across the population); the indicators worsened during the pandemic and had substantially recovered by late 2021.
Detection is the beginning
Most practices already have the searches, recalls and protocols to find this work. Shared-care protocols set out what monitoring is needed and who is responsible. The gap is follow-through:
- A monitoring recall is sent, but nobody checks the patient booked.
- A result is received, but it is not linked back to why it was requested.
- A hospital asks for a dose change, but the record still shows the old dose weeks later.
- A task is marked complete because someone believed it had been done.
Each of these looks like finished work in a task list. None of them is.
Verification, not attestation
The principle Reedley is being designed around is simple: work is verified by evidence from the source of truth, not by a person ticking a box — and the evidence has to prove the event itself. A change to the medication record is verified when the record shows the new dose; that proves the record changed, not that the patient is taking it. A blood test is verified when the result comes back for the patient. A booked appointment proves only that a booking exists: the review is verified when the appointment is recorded as attended, and until then the item stays open as pending. The same applies elsewhere: a sent message is not proof it was read, and a submitted referral is not proof it was accepted.
Checking these sources automatically will need approved access to clinical systems, which Reedley does not have today. A person’s report moves an item to actioned; verification comes from the record where Reedley can read it; where it cannot, a named person’s structured statement is accepted today, and that rule is under review.
A person's action matters — it moves work forward and records who did what — but on its own it means "actioned", not "done". Only when the source shows it happened should the item be closed as completed. And when work genuinely cannot be completed — the patient declined, or could not be contacted — that should be recorded explicitly, with a reason, rather than quietly disappearing.
Rules need owners
Monitoring intervals and review rules should be explicit, versioned and owned by named clinicians, because they vary by medicine, by protocol and by local agreement. In Reedley today, those rules are drafts with no clinical owner, and the product labels them as such. Rules are a clinical governance matter, not a software default.
Sources
- Avery AJ, et al. Investigating the prevalence and causes of prescribing errors in general practice: the PRACtICe study. British Journal of General Practice 2013.
- Elliott RA, et al. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Quality & Safety 2021;30(2):96.
- Fisher L, et al. Effect of the COVID-19 pandemic on medication safety indicators in primary care: OpenSAFELY. BMJ Medicine 2023;2:e000392.
- NHS England. Regional Medicines Optimisation Committee shared care protocols.
This article is general information about UK primary care. It is not clinical, legal or regulatory advice. Figures are taken from the cited sources and are not Reedley results.